• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌梗死后心力衰竭的发生时间及后续临床病程。

The timing of development and subsequent clinical course of heart failure after a myocardial infarction.

作者信息

Torabi Azam, Cleland John G F, Khan Nasrin K, Loh Puan H, Clark Andrew L, Alamgir Farqad, Caplin John L, Rigby Alan S, Goode Kevin

机构信息

Department of Cardiology, Hull Royal Infirmary, University of Hull Castle Hill Hospital, Kingston-upon-Hull, Castle Road, Cottingham, East Yorkshire HU16 5JQ, UK.

出版信息

Eur Heart J. 2008 Apr;29(7):859-70. doi: 10.1093/eurheartj/ehn096. Epub 2008 Mar 19.

DOI:10.1093/eurheartj/ehn096
PMID:18353754
Abstract

AIMS

Myocardial infarction (MI) is a common cause of heart failure (HF), which may develop early and persist or resolve, or develop late. The cumulative incidence, persistence, and resolution of HF after MI are poorly described. The aim of this study is to describe the natural history and prognosis of HF after an MI.

METHODS AND RESULTS

Patients with a death or discharge diagnosis of MI in 1998 were identified from records of hospitals providing services to a local community of 600 000 people. Records were scrutinized to identify the development of HF, defined as signs and symptoms consistent with that diagnosis and treated with loop diuretics. HF was considered to have resolved if diuretics could be stopped without recurrent symptoms. Totally, 896 patients were identified of whom 54% had died by December 2005. During the index admission, 199 (22.2%) patients died, many with HF, and a further 182 (20.3%) patients developed HF that persisted until discharge, of whom 121 died subsequent to discharge. Of 74 patients with transient HF that resolved before discharge, 41 had recurrent HF and 38 died during follow-up. After discharge, 145 (33%) patients developed HF for the first time, of whom 76 died during follow-up. Overall, of 281 deaths occurring after discharge, 235 (83.6%) were amongst inpatients who first developed HF.

CONCLUSION

The development of HF precedes death in most patients who die in the short- or long-term following an MI. Prevention of HF, predominantly by reducing the extent of myocardial damage and recurrent MI, and subsequent management could have a substantial impact on prognosis.

摘要

目的

心肌梗死(MI)是心力衰竭(HF)的常见病因,HF可能早期发生并持续存在或缓解,也可能晚期发生。心肌梗死后HF的累积发病率、持续存在情况及缓解情况鲜有描述。本研究旨在描述心肌梗死后HF的自然病史和预后。

方法与结果

从为当地60万人口社区提供服务的医院记录中,识别出1998年有死亡或出院诊断为心肌梗死的患者。仔细审查记录以确定HF的发生情况,HF定义为符合该诊断的体征和症状并接受襻利尿剂治疗。如果停用利尿剂后无复发症状,则认为HF已缓解。总共识别出896例患者,到2005年12月时其中54%已死亡。在首次住院期间,199例(22.2%)患者死亡,许多伴有HF,另有182例(20.3%)患者发生HF并持续至出院,其中121例出院后死亡。74例在出院前缓解的短暂性HF患者中,41例复发HF,38例在随访期间死亡。出院后,145例(33%)患者首次发生HF,其中76例在随访期间死亡。总体而言,出院后发生的281例死亡中,235例(83.6%)是首次发生HF的住院患者。

结论

在心肌梗死后短期或长期死亡的大多数患者中,HF的发生先于死亡。主要通过减少心肌损伤程度和复发性心肌梗死来预防HF,以及后续的管理可能对预后产生重大影响。

相似文献

1
The timing of development and subsequent clinical course of heart failure after a myocardial infarction.心肌梗死后心力衰竭的发生时间及后续临床病程。
Eur Heart J. 2008 Apr;29(7):859-70. doi: 10.1093/eurheartj/ehn096. Epub 2008 Mar 19.
2
Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction.老年首次心肌梗死患者住院死亡率下降,心力衰竭发病率上升。
J Am Coll Cardiol. 2009 Jan 6;53(1):13-20. doi: 10.1016/j.jacc.2008.08.067.
3
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.心肌梗死合并肺充血和/或左心室功能障碍稳定存活患者首次心力衰竭住院的预测因素:一项VALIANT研究
Eur Heart J. 2008 Mar;29(6):748-56. doi: 10.1093/eurheartj/ehn062. Epub 2008 Feb 28.
4
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.心肌梗死合并心力衰竭和左心室收缩功能障碍的国际视角:VALIANT注册研究
Eur Heart J. 2004 Nov;25(21):1911-9. doi: 10.1016/j.ehj.2004.08.006.
5
Long-term survival after heart failure: a contemporary population-based perspective.心力衰竭后的长期生存:基于当代人群的视角
Arch Intern Med. 2007 Mar 12;167(5):490-6. doi: 10.1001/archinte.167.5.490.
6
Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.回顾性索赔数据库分析,以确定肾素-血管紧张素系统药物、再住院率与心力衰竭或心肌梗死患者医疗费用之间的关系。
Clin Ther. 2008;30 Pt 2:2217-27. doi: 10.1016/j.clinthera.2008.12.005.
7
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry.急性心肌梗死后入院时的心力衰竭与中风风险:VALIANT注册研究
Eur Heart J. 2005 Oct;26(20):2114-9. doi: 10.1093/eurheartj/ehi352. Epub 2005 Jun 21.
8
Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).心力衰竭住院患者出院后死亡率的预测因素:来自心力衰竭住院患者启动挽救生命治疗组织项目(OPTIMIZE-HF)的分析。
Am Heart J. 2008 Oct;156(4):662-73. doi: 10.1016/j.ahj.2008.04.030.
9
Myocardial infarction and heart failure hospitalization rates in Maine, USA - variability along the urban-rural continuum.美国缅因州心肌梗死和心力衰竭住院率——城乡连续体中的变异性
Rural Remote Health. 2008 Apr-Jun;8(2):980. Epub 2008 Jun 26.
10
Heart failure after acute coronary syndrome: identify to treat better!急性冠状动脉综合征后的心力衰竭:明确诊断以更好地治疗!
Rev Port Cardiol. 2007 Apr;26(4):349-59.

引用本文的文献

1
A risk prediction model for acute kidney injury following acute heart failure in an emergency department cohort in China.中国急诊科队列中急性心力衰竭后急性肾损伤的风险预测模型
World J Emerg Med. 2025 Jul 1;16(4):348-356. doi: 10.5847/wjem.j.1920-8642.2025.068.
2
Incident heart failure and recurrent coronary events following acute myocardial infarction.急性心肌梗死后发生的心衰和复发性冠状动脉事件。
Eur Heart J. 2025 Apr 22;46(16):1540-1550. doi: 10.1093/eurheartj/ehae885.
3
A refined, minimally invasive, reproducible ovine ischaemia-reperfusion-infarction model using implantable defibrillators: Methodology and validation.
一种使用植入式除颤器的精细、微创、可重复的绵羊缺血-再灌注-梗死模型:方法与验证
Exp Physiol. 2025 Feb;110(2):215-229. doi: 10.1113/EP091760. Epub 2024 Dec 19.
4
The Comparison of the Effectiveness of Dapagliflozin and Empagliflozin in the Prevention of Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Network Meta-Analysis.达格列净与恩格列净预防2型糖尿病患者心血管结局有效性的比较:一项网状Meta分析
Cureus. 2024 Sep 19;16(9):e69711. doi: 10.7759/cureus.69711. eCollection 2024 Sep.
5
The relative impact of components of high residual risk on the long-term prognosis after AMI.急性心肌梗死后高残余风险各组成部分对长期预后的相对影响。
Int J Cardiol Cardiovasc Risk Prev. 2024 Jul 6;22:200310. doi: 10.1016/j.ijcrp.2024.200310. eCollection 2024 Sep.
6
3D bioprinted aged human post-infarct myocardium tissue model.3D生物打印的老年人心肌梗死后组织模型
Health Sci Rep. 2024 Apr 22;7(4):e1945. doi: 10.1002/hsr2.1945. eCollection 2024 Apr.
7
Timing of heart failure development and clinical outcomes in patients with acute myocardial infarction.急性心肌梗死患者心力衰竭发生的时间及临床结局
Front Cardiovasc Med. 2023 Jun 30;10:1193973. doi: 10.3389/fcvm.2023.1193973. eCollection 2023.
8
Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A COG-ALTE03N1 Report.儿童癌症幸存者中触珠蛋白基因表达与蒽环类药物相关的心肌病:一份儿童肿瘤学组ALTE03N1报告
JACC CardioOncol. 2023 Feb 7;5(3):392-401. doi: 10.1016/j.jaccao.2022.09.009. eCollection 2023 Jun.
9
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry.接受经皮冠状动脉介入治疗的急性心肌梗死后使用 SGLT2 抑制剂治疗的糖尿病患者的结局:SGLT2-I AMI PROTECT 登记研究。
Pharmacol Res. 2023 Jan;187:106597. doi: 10.1016/j.phrs.2022.106597. Epub 2022 Dec 5.
10
A randomized controlled clinical trial of prolonged balloon inflation during stent deployment strategy in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a pilot study.急性 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗中支架扩张时延长球囊扩张时间的随机对照临床试验:一项初步研究。
BMC Cardiovasc Disord. 2022 Feb 4;22(1):30. doi: 10.1186/s12872-022-02477-0.